Evaluation of a confidential method of excluding blood donors exposed to human immunodeficiency virus: studies on hepatitis and cytomegalovirus markers
- 1 March 1987
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 27 (2) , 207-209
- https://doi.org/10.1046/j.1537-2995.1987.27287150203.x
Abstract
A confidential self-administered questionnaire was given to all blood donors prior to donation (n = 95,917). The questionnaire describes groups at increased risk of acquired immunodeficiency syndrome (AIDS) and requires the donor to designate his blood either for laboratory purposes or for transfusion. In a previous communication, were reported that donors in the former group had a much higher prevalence of antibody to human immunodeficiency virus (HIV) than age, sex and clinic matched controls or a group of "miscellaneous" donors who did not fill out the form properly. In this communication, we report results of tests for other viral markers performed upon the three designation groups, namely laboratory-designated, miscellaneous and controls. We found that the former two groups had higher prevalence of antibody to hepatitis B surface antigen (anti-HBs), hepatitis B core antigen (anti-HBc) and cytomegalovirus (anti-CMV) than controls, but there were no differences in alanine aminotransferase (ALT) levels among the groups. In addition, the laboratory-designated group had a higher prevalence of hepatitis B surface antigen (HBsAg) than the general donor population. These data indicate that a questionnaire designed to ascertain AIDS high-risk donors is valuable in excluding donors who may be carriers of other viruses as well.This publication has 8 references indexed in Scilit:
- Evaluation of a confidential method of excluding blood donors exposed to human Immunodeficiency virusTransfusion, 1986
- Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated BloodAnnals of Internal Medicine, 1986
- Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusionTransfusion, 1985
- Hepatitis B Virus Antibody in Blood Donors and the Occurrence of Non-A, Non-B Hepatitis in Transfusion RecipientsAnnals of Internal Medicine, 1984
- Donor transaminase and recipient hepatitis. Impact on blood transfusion servicesJAMA, 1981
- Antibody to Hepatitis B Core Antigen in Blood Donors with a History of HepatitisTransfusion, 1981
- Serum Alanine Aminotransferase of Donors in Relation to the Risk of Non-A,Non-B Hepatitis in RecipientsNew England Journal of Medicine, 1981
- Type B Hepatitis after Transfusion with Blood Containing Antibody to Hepatitis B Core AntigenNew England Journal of Medicine, 1978